Technical Data
A1102-83G
AKAP9 (A Kinase (PRKA) Anchor Protein 9, PRKA9, CG-NAP, Yotiao, AKAP350, AKAP450, HYPERION, KIAA0803, AKAP120-like Protein, Kinase N-associated Protein, A-kinase Anchoring Protein 450, A-kinase anchor protein 350kD, Protein Kinase A Anchoring Protein 9, C
Description:
Applications:
Suitable for use in ELISA. Other applications have not been tested.

Recommended Dilutions:
Peptide ELISA Titer: 1:64,000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
100ug-20°CBlue IceHumanGoat
Concentration:
~0.5mg/ml
Immunogen:
Synthetic peptide corresponding to QRKAQSDGQSPSKK-C, from the N Terminus of human AKAP9 (NP_005742.4; NP_671714.1).
Purity:
Purified by peptide affinity chromatography.
Form
Supplied as a liquid in Tris saline, pH 7.3, 0.5% BSA, 0.02% sodium azide.
Specificity:
Recognizes AKAP9. Species sequence homology: human, canine. This antibody is expected to recognize isoforms 2 and 3 (NP_005742.4; NP_671714.1)
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Frank B, Wiestler M, Kropp S, Hemminki K, Spurdle AB, Sutter C, Wappenschmidt B, Chen X, Beesley J, Hopper JL, Meindl A, Kiechle M, Slanger T, Bugert P, Schmutzler RK, Bartram CR, Flesch-Janys D, Mutschelknauss E, Ashton K, Salazar R, Webb E, Hamann U, Brauch H, Justenhoven C, Ko YD, BrÃ1 4ning T, Silva Idos S, Johnson N, Pharoah PP, Dunning AM, Pooley KA, Chang-Claude J, Easton DF, Peto J, Houlston R, Chenevix-Trench G, Fletcher O, Burwinkel B, Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J. Natl. Cancer Inst. 2008 Mar 100 (6): 437-42. PMID: 18334708